miRNA-21 may serve as a promising noninvasive marker of glioma with a high diagnostic performance: a pooled analysis of 997 patients.

Xinli ZhaoZhihong XiaoBin LiHongwei LiBo YangTian LiZu-Bing Mei

Published in: Therapeutic advances in medical oncology (2021)

This meta-analysis demonstrated that miRNA-21 has high diagnostic performance and could serve as a promising noninvasive diagnostic marker for glioma. Further large prospective studies are needed to validate its diagnostic value and its prognostic significance and therapeutic effects.

Keyphrases

systematic review
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
case control
prognostic factors
randomized controlled trial
meta analyses
patient reported